Informational only — Not medical advice. Always consult a licensed healthcare provider.

Community data Updated 2 months ago

Indications

Sumatrex is a serotonin (5-HT1B/1D) receptor agonist, a member of the triptan group, used for the acute treatment of migraine with or without aura in adults. Limitations of use: It should be used only when a clear diagnosis of migraine headache has been established. It is not indicated for preventing migraine attacks, nor for the treatment of cluster headache.

⚠️ Always consult a registered physician before taking any medicine.

Pharmacology

Sumatriptan acts as an agonist at a vascular 5-hydroxytryptamine receptor subtype (probably belonging to the 5-HT family). It has only weak affinity for 5-HT, 5-HT, and 5-HT receptors, and shows no significant affinity (measured with standard radioligand binding assays) or pharmacological activity at 5-HT, 5-HT, or 5-HT receptor subtypes, nor at alpha-adrenergic, beta-adrenergic, dopamine, muscarinic, or benzodiazepine receptors. The vascular 5-HT receptor subtype activated by sumatriptan is found on cranial arteries in both dogs and primates, on the human basilar artery, and in the vasculature of human dura mater, where it mediates vasoconstriction. In humans, this action correlates with relief from migraine headache. Besides causing vasoconstriction, experimental data from animal studies show that sumatriptan also activates 5-HT receptors on the peripheral terminals of the trigeminal nerve that innervate cranial blood vessels. This action may also contribute to sumatriptan's antimigrainous effect in humans.

Pregnancy & Breastfeeding

Pregnancy Category C: well-controlled studies in pregnant women are lacking. Sumatriptan does pass into breast milk after a subcutaneous dose, so a nursing mother can limit her infant's exposure by not breastfeeding for 12 hours after taking Sumatriptan Tablets.

⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.

Dosage Reference

⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.

Adults: Sumatriptan nasal spray: A single dose is 10 mg. The maximum dose in any 24-hour period is 30 mg. Doses should be separated by at least one hour, or as directed by the physician. Sumatriptan tablets: In controlled clinical trials, single doses of 25 mg, 50 mg or 100 mg were effective for the acute treatment of migraine in adults. Evidence suggests that 50 mg and 100 mg doses may work better than 25 mg, but that 100 mg does not work better than 50 mg. Because people respond differently to Sumatriptan tablets, the dose should be chosen for each patient individually, weighing the possible benefit of a higher dose against the greater risk of side effects. If the headache returns, or if the patient has only a partial response to the first dose, the dose may be repeated after 2 hours. The total daily dose should not exceed 200 mg. If a headache returns after initial treatment with Sumatriptan injection, additional single Sumatriptan tablets (up to 100 mg per day) may be given, with at least 2 hours between tablet doses. The safety of treating more than an average of 4 headaches in a 30-day period has not been established. Use in children and adolescents: Sumatriptan is not recommended for patients under 18 years of age.

Side Effects & Interactions

Side Effects

No side-effect data recorded yet.

Key Interactions

Checker →